Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Long-Term Investments (2009 - 2026)

Updated

Alnylam Pharmaceuticals (ALNY) posted Long-Term Investments of $22.17 million for Q2 2026, down 67.7% from $68.59 million a year earlier and unchanged from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Long-Term Investments (2009 - 2026) Analysis & Trends

Since Q4 2009, Alnylam Pharmaceuticals has reported Long-Term Investments for 66 quarters.

  • Annual Long-Term Investments shows a five-year compound annual growth rate of -11.5% (FY2020 to FY2025).
  • In prior years, Alnylam Pharmaceuticals' Long-Term Investments was $68.59 million in FY2024 (+38.9%), $49.39 million in FY2023 (unchanged), $49.39 million in FY2022 (+20.8%) and $40.89 million in FY2021 (+0.4%).
  • Quarterly Long-Term Investments has run from a low of $22.17 million in Q4 2025 to a high of $68.59 million in Q2 2025 over five years.
  • On a year-over-year basis, Long-Term Investments has declined in each of the last four quarters, with an average decline of 9.1% over the last eight quarters.
  • The strongest year-over-year quarter for Long-Term Investments in the past five years was Q3 2021, with growth of 65.4%; the weakest was Q4 2025, with a decline of 67.7%.
  • According to Business Quant data, Long-Term Investments for the three prior quarters was $22.17 million (Q1 2026), $22.17 million (Q4 2025) and $51.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 266.00 Mn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 2.62 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 5.79 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 22.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.17 Mn
Mar 31, 2026 22.17 Mn
Dec 31, 2025 22.17 Mn
Sep 30, 2025 51.31 Mn
Jun 30, 2025 68.59 Mn
Mar 31, 2025 68.59 Mn
Dec 31, 2024 68.59 Mn
Sep 30, 2024 68.59 Mn
Jun 30, 2024 49.39 Mn
Mar 31, 2024 49.39 Mn
Dec 31, 2023 49.39 Mn
Sep 30, 2023 49.39 Mn
Jun 30, 2023 49.39 Mn
Mar 31, 2023 49.39 Mn
Dec 31, 2022 49.39 Mn
Sep 30, 2022 49.39 Mn
Jun 30, 2022 49.39 Mn
Mar 31, 2022 40.89 Mn
Dec 31, 2021 40.89 Mn
Sep 30, 2021 40.89 Mn
API Access

Alnylam Pharmaceuticals Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ALNY&period=max&api_key=YOUR_API_KEY